AstraZeneca PLCAZNNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, above historical average, modest growth trend.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$15.44B
↑ 80% above average
Average (9y)
$8.58B
Historical baseline
Range
High:$15.44B
Low:$5.11B
CAGR
+9.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $15.44B | +15.0% |
| 2023 | $13.42B | +47.7% |
| 2022 | $9.09B | +77.7% |
| 2021 | $5.11B | -36.8% |
| 2020 | $8.08B | +20.4% |
| 2019 | $6.71B | -5.6% |
| 2018 | $7.11B | +7.4% |
| 2017 | $6.62B | -9.0% |
| 2016 | $7.28B | +4.5% |
| 2015 | $6.96B | - |